Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ATR logo ATR
Upturn stock ratingUpturn stock rating
ATR logo

AptarGroup Inc (ATR)

Upturn stock ratingUpturn stock rating
$155.82
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: ATR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

7 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Year Target Price $175

Year Target Price $175

Analyst’s Price TargetsFor last 52 week
$175Target price
Low$130.46
Current$155.82
high$176.99

Analysis of Past Performance

Type Stock
Historic Profit 3.91%
Avg. Invested days 42
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 10.29B USD
Price to earnings Ratio 28.49
1Y Target Price 175
Price to earnings Ratio 28.49
1Y Target Price 175
Volume (30-day avg) -
Beta 0.59
52 Weeks Range 130.46 - 176.99
Updated Date 06/29/2025
52 Weeks Range 130.46 - 176.99
Updated Date 06/29/2025
Dividends yield (FY) 1.16%
Basic EPS (TTM) 5.47

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 10.42%
Operating Margin (TTM) 13.05%

Management Effectiveness

Return on Assets (TTM) 7.13%
Return on Equity (TTM) 15.05%

Valuation

Trailing PE 28.49
Forward PE 28.49
Enterprise Value 11211041406
Price to Sales(TTM) 2.89
Enterprise Value 11211041406
Price to Sales(TTM) 2.89
Enterprise Value to Revenue 3.15
Enterprise Value to EBITDA 14.34
Shares Outstanding 66040700
Shares Floating 65490578
Shares Outstanding 66040700
Shares Floating 65490578
Percent Insiders 1.06
Percent Institutions 96.04

Analyst Ratings

Rating 4.29
Target Price 175
Buy 1
Strong Buy 4
Buy 1
Strong Buy 4
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

AptarGroup Inc

stock logo

Company Overview

overview logo History and Background

AptarGroup, Inc. was founded in 1992 as a spin-off from Seaquist Closures, originally part of Pittway Corporation. The company specializes in dispensing, sealing, and protective solutions for a variety of industries.

business area logo Core Business Areas

  • Beauty + Home: Provides dispensing solutions such as pumps, sprayers, and closures for the beauty, personal care, and home care markets.
  • Pharma: Offers drug delivery devices, including nasal spray pumps, metered dose inhalers, and injectable components, for the pharmaceutical industry.
  • Food + Beverage: Supplies dispensing and sealing solutions for the food and beverage industries, including closures, dispensing valves, and tamper-evident systems.

leadership logo Leadership and Structure

The leadership team includes Stephan Tanda (President and CEO). The company operates with a decentralized structure, with each business segment having its own management team.

Top Products and Market Share

overview logo Key Offerings

  • Product Name 1: Airless dispensing systems (Beauty + Home). Market share is estimated to be between 20-25% of the global airless packaging market. Competitors include HCP Packaging, Quadpack, and Cosmogen.
  • Product Name 2: Nasal spray pumps (Pharma). Aptar Pharma is considered a leader in this space. Competitors include Berry Global, Nemera, and Gerresheimer.
  • Product Name 3: SimpliSqueeze valve closures (Food + Beverage). Market share varies by region and application. Competitors include Guala Closures, Crown Holdings, and Silgan Holdings.

Market Dynamics

industry overview logo Industry Overview

The dispensing and packaging solutions industry is driven by consumer demand for convenience, sustainability, and product protection. Key trends include increasing demand for e-commerce packaging, sustainable materials, and innovative dispensing technologies.

Positioning

AptarGroup is a global leader in dispensing, sealing, and protective solutions. Its competitive advantages include its broad product portfolio, strong customer relationships, and global manufacturing footprint.

Total Addressable Market (TAM)

The global dispensing and packaging market is estimated to be over $100 billion. AptarGroup holds a significant share but has room to grow by focusing on sustainable solutions, expanding into emerging markets, and developing innovative technologies.

Upturn SWOT Analysis

Strengths

  • Global presence
  • Strong R&D capabilities
  • Diversified product portfolio
  • Strong customer relationships
  • Reputation for innovation

Weaknesses

  • Exposure to raw material price fluctuations
  • Dependence on key customers
  • Potential for product recalls
  • Currency exchange rate volatility
  • Complex supply chain

Opportunities

  • Growth in emerging markets
  • Increasing demand for sustainable packaging
  • Expansion into new applications
  • Strategic acquisitions
  • Increased demand for e-commerce packaging

Threats

  • Intense competition
  • Economic downturns
  • Changing consumer preferences
  • Regulatory changes
  • Disruptive technologies

Competitors and Market Share

competitor logo Key Competitors

  • BERY
  • NEM
  • PKG

Competitive Landscape

AptarGroup's advantages include its global reach, strong R&D capabilities, and diverse product portfolio. Disadvantages include exposure to raw material price fluctuations and intense competition.

Major Acquisitions

Voluntis

  • Year: 2021
  • Acquisition Price (USD millions): 92
  • Strategic Rationale: Voluntis brought digital therapeutics expertise in oncology and diabetes into the digital health space within Aptar Digital Health.

Growth Trajectory and Initiatives

Historical Growth: AptarGroup's historical growth has been driven by organic growth, acquisitions, and expansion into new markets.

Future Projections: Analyst estimates suggest continued growth for AptarGroup, driven by increasing demand for sustainable packaging and drug delivery solutions.

Recent Initiatives: Recent strategic initiatives include investments in sustainable materials, expansion of manufacturing capacity in emerging markets, and acquisitions of companies with complementary technologies.

Summary

AptarGroup is a leading global provider of dispensing and sealing solutions with a diversified product portfolio and strong customer relationships. Its strengths lie in its innovation and global presence, while potential weaknesses include raw material price volatility and intense competition. Growth opportunities include expansion into emerging markets and sustainable packaging, but the company must navigate economic uncertainties and changing consumer preferences. AptarGroup appears fundamentally sound, but is exposed to macroeconomic risks.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • AptarGroup Investor Relations
  • SEC Filings
  • Industry Reports
  • Analyst Reports

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share data is based on estimates and may vary. Financial data is subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About AptarGroup Inc

Exchange NYSE
Headquaters Crystal Lake, IL, United States
IPO Launch date 1993-04-21
President, CEO & Executive Director Mr. Stephan B. Tanda
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 13000
Full time employees 13000

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.